Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Sees Significant Increase in Short Interest

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the target of a large increase in short interest in January. As of January 15th, there was short interest totalling 4,300 shares, an increase of 207.1% from the December 31st total of 1,400 shares. Based on an average daily trading volume, of 11,200 shares, the days-to-cover ratio is currently 0.4 days.

Invesco Nasdaq Biotechnology ETF Price Performance

Shares of IBBQ traded up $0.02 during trading hours on Wednesday, hitting $22.57. The stock had a trading volume of 3,356 shares, compared to its average volume of 7,009. The stock has a market capitalization of $39.95 million, a price-to-earnings ratio of 17.39 and a beta of 0.61. The company’s fifty day moving average is $22.19 and its two-hundred day moving average is $23.26. Invesco Nasdaq Biotechnology ETF has a 52 week low of $20.14 and a 52 week high of $24.84.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The company also recently disclosed a dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 23rd were issued a dividend of $0.0619 per share. The ex-dividend date was Monday, December 23rd.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. ORG Partners LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF during the 3rd quarter valued at $25,000. Strategic Financial Concepts LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF in the 4th quarter valued at about $1,699,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Invesco Nasdaq Biotechnology ETF by 22.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock worth $6,156,000 after acquiring an additional 48,137 shares during the last quarter.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.